Phloretin either alone or in combination with duloxetine alleviates the STZ-induced diabetic neuropathy in rats
- 1 May 2018
- journal article
- research article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 101, 821-832
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Insulin resistance in the nervous systemTrends in Endocrinology & Metabolism, 2012
- Diabetes-induced myelin abnormalities are associated with an altered lipid pattern: protective effects of LXR activationJournal of Lipid Research, 2012
- Duloxetine, Pregabalin, and Duloxetine Plus Gabapentin for Diabetic Peripheral Neuropathic Pain Management in Patients With Inadequate Pain Response to Gabapentin: An Open-Label, Randomized, Noninferiority ComparisonMayo Clinic Proceedings, 2011
- DuloxetineClinical Pharmacokinetics, 2011
- Increase in IL-6 levels among major depressive disorder patients after a 6-week treatment with duloxetine 60 mg/day: a preliminary observationNeuropsychiatric Disease and Treatment, 2011
- Hyperglycemia magnifies Schwann cell dysfunction and cell death triggered by PA-induced lipotoxicityBrain Research, 2011
- Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and TreatmentsDiabetes Care, 2010
- Endoneurial microvascular pathology in feline diabetic neuropathyMicrovascular Research, 2008
- Oxidative stress and neurodegeneration: where are we now?Journal of Neurochemistry, 2006
- The occurrence of superoxide anion in the reaction of reduced phenazine methosulfate and molecular oxygenBiochemical and Biophysical Research Communications, 1972